Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    4%
    Check dated 2024-11-23T04:26:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading study data in various formats and additional participant and study information fields.
    Difference
    4%
    Check dated 2024-11-15T23:02:59.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:47:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:31:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-10-17T20:20:32.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T05:36:05.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.